On Mar. 20, 2018, in response to the Ebola outbreak that claimed more than 10,000 lives in West Africa in 2014, Canada and China announced a joint project to develop an Ebola vaccine.

Created by the Chinese Academy of Military Medical Sciences’ Bioengineering Institute and CanSino Biologics, the vaccine was approved by Chinese regulators and the National Research Council of Canada (NRC) developed the manufacturing process.